Efficacy of EC-MPS compared to MMF in Chinese patients as measured by the incidence of biopsy proven acute rejection, graft loss, or death within six months of treatment in de novo renal transplant recipients. [clinicaltrials_resource:4f1529a1103e6cf67ce3fb14d7950f1b]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Efficacy of EC-MPS compared to MMF in Chinese patients as measured by the incidence of biopsy proven acute rejection, graft loss, or death within six months of treatment in de novo renal transplant recipients. [clinicaltrials_resource:4f1529a1103e6cf67ce3fb14d7950f1b]
Bio2RDF identifier
4f1529a1103e6cf67ce3fb14d7950f1b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4f1529a1103e6cf67ce3fb14d7950f1b
measure [clinicaltrials_vocabulary:measure]
Efficacy of EC-MPS compared to ...... o renal transplant recipients.
identifier
clinicaltrials_resource:4f1529a1103e6cf67ce3fb14d7950f1b
title
Efficacy of EC-MPS compared to ...... o renal transplant recipients.
@en
type
label
Efficacy of EC-MPS compared to ...... 529a1103e6cf67ce3fb14d7950f1b]
@en